Zacks Rank #5 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
BPY: 23.40 (-0.01), BIO: 120.32 (-0.04), BALT: 2.47 (-0.11), CVE: 20.70 (-0.25), APC: 83.08 (-1.16)
Affymetrix, Binding Site Group Ink Distribution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 4:25PM CST
Provider of life science tools and molecular diagnostic products, Affymetrix Inc. (AFFX), recently announced that its eBioscience business has entered into a multi-year distribution agreement with The Binding Site Group Ltd.
HBIO: 5.15 (-0.09), BIO: 120.32 (-0.04), ILMN: 186.22 (+2.72), AFFX: 9.80 (+0.05)
Affymetrix Axiom Genotyping Platform Selected by Toshiba - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 5:10PM CST
The Axiom Genotyping Solution platform of Affymetrix (AFFX) has been selected by Toshiba's Healthcare Company as the platform for its newly launched genotyping service.
HBIO: 5.15 (-0.09), BIO: 120.32 (-0.04), ILMN: 186.22 (+2.72), AFFX: 9.80 (+0.05)
Zacks Rank #5 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 26, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
BUD: 115.51 (+0.09), BIO: 120.32 (-0.04), AVHI: 13.84 (+0.19), BBL: 42.86 (-0.19), WBAI: 19.70 (+0.19)
Bio-Rad Receives Premarket Application Approval for Its Geenius HIV 1/2 Supplemental Assay
Marketwired - Wed Nov 19, 3:45PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.
BIO: 120.32 (-0.04), BIO.B: 120.51 (unch)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Bio-Rad Laboratories, Inc.
PR Newswire - Wed Nov 12, 12:44PM CST
Levi & Korsinsky, LLP is investigating Bio-Rad Laboratories, Inc. ("Bio-Rad" or the "Company"
BIO: 120.32 (-0.04)
Lifshitz & Miller Law Firm Announces Investigation of Barrett Business Services, Inc., Bio-Rad Laboratories, Inc., Pingtan Marine Enterprise Ltd., Rayonier Inc. and Salix Pharmaceuticals, Ltd.
PR Newswire - Tue Nov 11, 11:10AM CST
Barrett Business Services, Inc.
RYN: 28.31 (unch), BIO: 120.32 (-0.04), BBSI: 28.34 (+0.38), SLXP: 114.92 (-1.18), PME: 2.00 (+0.10)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces an Investigation into Possible Breaches of Fiduciary Duties by the Board of Directors of Bio-Rad Laboratories, Inc.
Business Wire - Fri Nov 07, 3:39PM CST
Rigrodsky & Long, P.A. announces that it is investigating whether certain officers and directors of Bio-Rad Laboratories, Inc. ("Bio-Rad" or the "Company"
BIO: 120.32 (-0.04)
Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
BWEN: 5.67 (+0.11), AIRM: 43.03 (-0.10), CPF: 21.00 (+0.95), BIO: 120.32 (-0.04), BALT: 2.47 (-0.11)
Ryan & Maniskas, LLP Announces Investigation of Bio-Rad Laboratories, Inc.
PR Newswire - Wed Nov 05, 6:30PM CST
Ryan & Maniskas, LLP has commenced an investigation into potential securities law violations by certain officers of Bio-Rad Laboratories, Inc. ("Bio-Rad" or the "Company"
BIO: 120.32 (-0.04)
BIO-RAD INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Bio-Rad Laboratories, Inc. Following Bribery Settlement with Securities and Exchange Commission and the U.S. Department of Justice
Business Wire - Wed Nov 05, 3:58PM CST
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq. a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"
BIO: 120.32 (-0.04)
Bio-Red Laboratories' (BIO) CEO Norman Schwartz on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 8:33PM CST
BIO: 120.32 (-0.04)
Bio-Rad posts 3Q profit
Automated Insights - Tue Nov 04, 5:36PM CST
HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO) on Tuesday reported net income of $11.5 million, or 39 cents per share, in its third quarter.
BIO: 120.32 (-0.04), BIO.B: 120.51 (unch)
Bio-Rad Laboratories (BIO) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 3:55PM CST
BIO: 120.32 (-0.04)
Faruqi & Faruqi, LLP is Investigating Bio-Rad Laboratories, Inc. (BIO) on Behalf of its Shareholders
PR Newswire - Tue Nov 04, 3:48PM CST
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at Bio-Rad Laboratories, Inc. ("Bio-Rad" or the "Company"
BIO: 120.32 (-0.04)
Robbins Arroyo LLP Is Investigating the Officers and Directors of Bio-Rad Laboratories, Inc. (BIO) on Behalf of Shareholders
PR Newswire - Tue Nov 04, 3:47PM CST
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Bio-Rad Laboratories, Inc. (NYSE: BIO) breached their fiduciary duties to shareholders. Bio-Rad manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets.
BIO: 120.32 (-0.04)
Bio-Rad Labs misses by $0.47, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 3:43PM CST
BIO: 120.32 (-0.04)